Key result
In a low socioeconomic status cohort in India, overall in-hospital mortality for acute coronary syndrome was 3.2%, being higher in STEMI than in NSTE-ACS.
Why the study?
There is a scarcity of data on the demographic profile, management strategies, and outcomes of ACS in the low socioeconomic status population of India.
Cohort (n=621)
No
With implementation of evidence-based pharmacotherapy and interventions, favorable in-hospital outcomes comparable to developed countries can be achieved in low socioeconomic status ACS patients in India.
Answers are grounded in this paper and cite their sources.
Low in-hospital ACS mortality in this Indian low-SES cohort may support evidence-based care; leaves open generalizability and causal confirmation.
BACKGROUND: Coronary artery disease is the leading cause of mortality in India. There is scarcity of data on demographic profile and outcomes of acute coronary syndrome (ACS) in low socioeconomic status (SES) population of India. OBJECTIVES: This study was undertaken to determine the clinical presentation, management strategies, and in-hospital outcomes of ACS in low SES population. METHODS: We conducted 1-year prospective observational cohort study of ACS patients admitted at Employees State Insurance Corporation unit of our tertiary care cardiac center. Clinical parameters, management strategies, and in-hospital outcomes of 621 patients enrolled during the study period from February 2015 to January 2016 were studied. RESULTS: Mean age of patients was 56.06 ± 11.29 years. Majority (62%) of the patients had ST elevation myocardial infarction (STEMI), whereas Non-ST elevation acute coronary syndrome (NSTE-ACS) was seen in 38% of the patients. Median time from symptom onset to hospital admission was 285 min with wide range from 105 to 1765 min. Coronary angiography was performed in 81% of patient population. Single-vessel disease (SVD) was the most common pattern (seen in 43.3%) of coronary artery involvement with left anterior descending coronary artery (LAD) being the most frequently involved vessel (62.8%). Pharmaco-invasive approach was the preferred strategy. Overall percutaneous coronary intervention (PCI) rates were 59.1% (62.1% in STEMI and 54.2% in NSTE-ACS). Overall in-hospital mortality was 3.2%, being significantly higher in STEMI (4.2%) as compared with NSTE-ACS (1.7%). CONCLUSIONS: With implementation of evidence-based pharmacotherapy and interventions, outcomes comparable with developed countries can be achieved even in low SES populations of developing world.
No takes yet. Share an insight, caveat, or question.
Sidhu et al. (2020) conducted a cohort in Acute Coronary Syndrome (n=621). Standard of care (pharmaco-invasive approach and PCI) was evaluated on In-hospital mortality. In a low socioeconomic status cohort in India, overall in-hospital mortality for acute coronary syndrome was 3.2%, being higher in STEMI than in NSTE-ACS.
Synapse has enriched 10 related papers. Consider them for comparative context: